292 related articles for article (PubMed ID: 10731472)
1. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement.
Barber MD; McMillan DC; Preston T; Ross JA; Fearon KC
Clin Sci (Lond); 2000 Apr; 98(4):389-99. PubMed ID: 10731472
[TBL] [Abstract][Full Text] [Related]
2. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.
Barber MD; Ross JA; Voss AC; Tisdale MJ; Fearon KC
Br J Cancer; 1999 Sep; 81(1):80-6. PubMed ID: 10487616
[TBL] [Abstract][Full Text] [Related]
3. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia.
Barber MD; Fearon KC; Tisdale MJ; McMillan DC; Ross JA
Nutr Cancer; 2001; 40(2):118-24. PubMed ID: 11962246
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients.
Barber MD; Preston T; McMillan DC; Slater C; Ross JA; Fearon KC
Clin Sci (Lond); 2004 Apr; 106(4):359-64. PubMed ID: 14624668
[TBL] [Abstract][Full Text] [Related]
5. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.
Wigmore SJ; Barber MD; Ross JA; Tisdale MJ; Fearon KC
Nutr Cancer; 2000; 36(2):177-84. PubMed ID: 10890028
[TBL] [Abstract][Full Text] [Related]
6. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.
Fouladiun M; Körner U; Bosaeus I; Daneryd P; Hyltander A; Lundholm KG
Cancer; 2005 May; 103(10):2189-98. PubMed ID: 15822132
[TBL] [Abstract][Full Text] [Related]
7. Metabolic changes in elderly cancer patients after glucose ingestion. The role of tumor necrosis factor-alpha.
Gambardella A; Tortoriello R; Tagliamonte MR; Paolisso G; Varricchio M
Cancer; 1997 Jan; 79(1):177-84. PubMed ID: 8988743
[TBL] [Abstract][Full Text] [Related]
8. Leucine kinetics in patients with benign disease, non-weight-losing cancer, and cancer cachexia: studies at the whole-body and tissue level and the response to nutritional support.
Shaw JH; Humberstone DA; Douglas RG; Koea J
Surgery; 1991 Jan; 109(1):37-50. PubMed ID: 1984636
[TBL] [Abstract][Full Text] [Related]
9. Protein and energy metabolism in chronic bacterial infection: studies in melioidosis.
Paton NI; Angus B; Chaowagul W; Simpson AJ; Suputtamongkol Y; Elia M; Calder G; Milne E; White NJ; Griffin GE
Clin Sci (Lond); 2001 Jan; 100(1):101-10. PubMed ID: 11115424
[TBL] [Abstract][Full Text] [Related]
10. Glucose flux in relation to energy expenditure in malnourished patients with and without cancer during periods of fasting and feeding.
Edén E; Edström S; Bennegård K; Scherstén T; Lundholm K
Cancer Res; 1984 Apr; 44(4):1718-24. PubMed ID: 6367972
[TBL] [Abstract][Full Text] [Related]
11. Altered insulin response to glucose in weight-losing cancer patients.
Rofe AM; Bourgeois CS; Coyle P; Taylor A; Abdi EA
Anticancer Res; 1994; 14(2B):647-50. PubMed ID: 8010722
[TBL] [Abstract][Full Text] [Related]
12. Fish oil attenuates adrenergic overactivity without altering glucose metabolism during an oral glucose load in haemodialysis patients.
Delarue J; Guillodo MP; Guillerm S; Elbaz A; Marty Y; Clèdes J
Br J Nutr; 2008 May; 99(5):1041-7. PubMed ID: 17977474
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia.
Fearon KC; Barber MD; Moses AG; Ahmedzai SH; Taylor GS; Tisdale MJ; Murray GD
J Clin Oncol; 2006 Jul; 24(21):3401-7. PubMed ID: 16849754
[TBL] [Abstract][Full Text] [Related]
14. Nutritional support and quality of life in stable chronic obstructive pulmonary disease (COPD) patients.
Planas M; Alvarez J; García-Peris PA; de la Cuerda C; de Lucas P; Castellà M; Canseco F; Reyes L
Clin Nutr; 2005 Jun; 24(3):433-41. PubMed ID: 15896431
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation.
Montaurier C; Morio B; Bannier S; Derost P; Arnaud P; Brandolini-Bunlon M; Giraudet C; Boirie Y; Durif F
Brain; 2007 Jul; 130(Pt 7):1808-18. PubMed ID: 17535833
[TBL] [Abstract][Full Text] [Related]
16. Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia.
Lundholm K; Daneryd P; Körner U; Hyltander A; Bosaeus I
Int J Oncol; 2004 Mar; 24(3):505-12. PubMed ID: 14767534
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
18. Meal-feeding studies in mice: effects of diet on blood lipids and energy expenditure.
Parks EJ; Schneider TL; Baar RA
Comp Med; 2005 Feb; 55(1):24-9. PubMed ID: 15766205
[TBL] [Abstract][Full Text] [Related]
19. Effects of oral fat perception by modified sham feeding on energy expenditure, hormones and appetite profile in the postprandial state.
Smeets AJ; Lejeune MP; Westerterp-Plantenga MS
Br J Nutr; 2009 May; 101(9):1360-8. PubMed ID: 18814804
[TBL] [Abstract][Full Text] [Related]
20. Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer: a randomized, placebo-controlled trial.
Simons JP; Schols AM; Hoefnagels JM; Westerterp KR; ten Velde GP; Wouters EF
Cancer; 1998 Feb; 82(3):553-60. PubMed ID: 9452274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
